Form4insider filings, from the source

Company · CIK 0001425205 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

IOVANCE BIOTHERAPEUTICS, INC. · IOVA

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 8, 2026 FMForm 4 →Sep 10, 5:01 pm EDTFrederick G VogtInterim CEO & General Counsel, Director22,264$8.70$57,751595,447—
Sep 8, 2026 FMForm 4 →Sep 10, 5:00 pm EDTIgor BilinskyChief Operating Officer11,789$8.70$34,591142,074—
Sep 8, 2026 FMForm 4 →Sep 10, 5:00 pm EDTRaj K. PuriChief Regulatory Officer14,244$8.70$38,959256,364—
Sep 1, 2026 FMForm 4 →Sep 3, 5:02 pm EDTFrederick G VogtInterim CEO & General Counsel, Director59,371$8.28$146,573586,459—
Sep 1, 2026 FMForm 4 →Sep 3, 5:02 pm EDTRaj K. PuriChief Regulatory Officer7,978$8.28$20,766251,076—
Sep 1, 2026 FMForm 4 →Sep 3, 5:00 pm EDTIgor BilinskyChief Operating Officer13,261$8.28$37,028138,237—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 8, 2026 MForm 4 →Sep 10, 5:01 pm EDTFrederick G VogtInterim CEO & General Counsel, Director15,626——93,756—
Sep 8, 2026 MForm 4 →Sep 10, 5:00 pm EDTIgor BilinskyChief Operating Officer7,813——46,878—
Sep 8, 2026 MForm 4 →Sep 10, 5:00 pm EDTRaj K. PuriChief Regulatory Officer9,766——58,599—
Sep 1, 2026 MForm 4 →Sep 3, 5:02 pm EDTFrederick G VogtInterim CEO & General Counsel, Director41,669——83,338—
Sep 1, 2026 MForm 4 →Sep 3, 5:02 pm EDTRaj K. PuriChief Regulatory Officer5,470——10,939—
Sep 1, 2026 MForm 4 →Sep 3, 5:00 pm EDTIgor BilinskyChief Operating Officer8,789——17,580—